Common Stock, Shares, Outstanding of Viracta Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Viracta Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2024.
  • Viracta Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2024 was 39,744,222, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Viracta Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 39,744,222 +1,119,669 +2.9% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 39,417,171 +836,817 +2.2% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 39,272,434 +861,499 +2.2% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 39,093,509 +748,369 +2% 31 Dec 2023 10-Q 13 Nov 2024 2024 Q3
Q3 2023 38,624,553 +721,704 +1.9% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 38,580,354 +1,026,041 +2.7% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 38,410,935 +924,758 +2.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 38,345,140 +920,277 +2.5% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 37,902,849 +621,623 +1.7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 37,554,313 +413,496 +1.1% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 37,486,177 +449,883 +1.2% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 37,424,863 +36,518,876 +4031% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 37,281,226 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 37,140,817 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 37,036,294 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 905,987 +262,789 +41% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 643,198 -36,830,802 -98% 31 Dec 2019 8-K/A 23 Mar 2021
Q4 2018 37,474,000 +3,183,000 +9.3% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q4 2017 34,291,000 +13,366,000 +64% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q4 2016 20,925,000 +6,505,000 +45% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 14,420,000 -51,682,000 -78% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q4 2014 66,102,000 +11,758,000 +22% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 54,344,000 +2,779,000 +5.4% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 51,565,000 +4,791,000 +10% 31 Dec 2012 10-K 06 Mar 2014 2013 FY
Q4 2011 46,774,000 +1,402,000 +3.1% 31 Dec 2011 10-K 13 Mar 2013 2012 FY
Q4 2010 45,372,000 31 Dec 2010 10-K 14 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.